Chipscreen(688321)
Search documents
微芯生物:向特定对象发行股票注册申请获中国证监会同意批复
Xin Lang Cai Jing· 2025-12-02 07:56
微芯生物12月2日公告,公司于近日收到中国证监会出具的批复文件,同意公司向特定对象发行股票的 注册申请。批复自同意注册之日起12个月内有效。公司需在规定期限内办理本次向特定对象发行股票的 相关事项,并及时履行信息披露义务。 登录新浪财经APP 搜索【信披】查看更多考评等级 ...
微芯生物定增股票申请获得中国证监会同意注册批复
Zhi Tong Cai Jing· 2025-12-02 07:50
微芯生物(688321.SH)发布公告,公司于近日收到中国证券监督管理委员会出具的《关于同意深圳微芯 生物科技股份有限公司向特定对象发行股票注册的批复》,同意公司向特定对象发行股票的注册申请。 ...
微芯生物(688321.SH)定增股票申请获得中国证监会同意注册批复
智通财经网· 2025-12-02 07:45
智通财经APP讯,微芯生物(688321.SH)发布公告,公司于近日收到中国证券监督管理委员会出具的 《关于同意深圳微芯生物科技股份有限公司向特定对象发行股票注册的批复》,同意公司向特定对象发 行股票的注册申请。 ...
微芯生物:向特定对象发行股票申请获证监会同意注册批复
Xin Lang Cai Jing· 2025-12-02 07:40
Core Viewpoint - The company has received approval from the China Securities Regulatory Commission for a specific stock issuance, allowing it to proceed with its capital-raising efforts [1] Group 1 - The approval permits Shenzhen Micron Technology Co., Ltd. to issue stocks to specific investors [1] - The approval is valid for 12 months, during which the company must adhere to the submitted application documents and implementation plan [1] - The company is required to report any significant events to the Shanghai Stock Exchange before the completion of the issuance [1] Group 2 - The company's board of directors will handle the necessary matters within the stipulated timeframe and ensure timely disclosure of information [1]
微芯生物向特定对象发行股票申请审核状态变更为注册生效
Zheng Quan Shi Bao Wang· 2025-12-02 02:46
微芯生物本次拟向特定对象发行股票,拟发行数量不超过5812.53万股,预计募集资金9.50亿元。本次发 行保荐机构为国投证券股份有限公司。 微芯生物(688321)向特定对象发行股票申请审核状态变更为注册生效。 ...
微芯生物(688321) - 关于股份回购进展公告
2025-12-01 09:31
证券代码:688321 证券简称:微芯生物 公告编号:2025-077 | 回购方案首次披露日 | 2025/11/1 | | --- | --- | | 回购方案实施期限 | 待董事会审议通过后 个月 12 | | 预计回购金额 | 1,000万元~1,500万元 | | 回购用途 | □减少注册资本 √用于员工持股计划或股权激励 | | | □用于转换公司可转债 □为维护公司价值及股东权益 | | 累计已回购股数 | 0股 | | 累计已回购股数占总股本比例 | 0% | | 累计已回购金额 | 0元 | | 实际回购价格区间 | 0元/股~0元/股 | 深圳微芯生物科技股份有限公司 关于股份回购进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 一、回购股份的基本情况 2025 年 10 月 30 日,深圳微芯生物科技股份有限公司(以下简称"公司") 召开第三届董事会第十七次会议,审议通过了《关于以集中竞价交易方式回购公 司股份方案的议案》。同意公司使用不低于人民币 1,000 万元(含),不超过人民 币 1,50 ...
捐赠数千万港元!中国平安、阳光保险、水滴等险企驰援香港大埔火灾救援
Bei Jing Shang Bao· 2025-11-27 14:45
Core Viewpoint - A major fire occurred in Hong Kong's Tai Po district, resulting in significant casualties and prompting various sectors to respond with support and donations for emergency relief efforts [1] Group 1: Insurance Industry Response - China Ping An initiated a donation of 10 million HKD for emergency relief and post-disaster recovery efforts, providing essential supplies and financial support to affected residents [1] - Sunshine Insurance Group announced an emergency donation of 10 million HKD to assist in the fire rescue efforts in Tai Po [1] - Waterdrop Inc. pledged a donation of 1 million HKD to support the rescue efforts for residents impacted by the fire [1] - Yunfeng Financial Group and its subsidiary, Wantong Insurance, committed to a donation of 10 million HKD specifically for medical treatment, emergency housing, and transitional living assistance for affected residents [1] - The Fosun Public Welfare Foundation, in collaboration with Fosun International and other affiliated companies, donated 10 million HKD for urgent rescue and post-disaster reconstruction efforts [1]
微芯生物(688321) - 2025年第一次临时股东大会会议资料
2025-11-27 08:45
深圳微芯生物科技股份有限公司 2025 年第一次临时股东大会会议资料 2025 年 12 月 5 日 深圳 深圳微芯生物科技股份有限公司 2025 年第一次临时股东大会会议资料 目录 | 股东大会会议须知 3 | | --- | | 2025 年第一次临时股东大会议程 7 | | 《关于提请股东大会延长2024年度向特定对象发行A股股票所涉股东大会决议 | | 有效期及授权有效期的议案》 10 | | 《关于变更注册资本、取消监事会并修订<公司章程>及其附件的议案》 12 | | 《关于修订及制定公司部分治理制度的议案》 14 | 2 深圳微芯生物科技股份有限公司 2025 年第一次临时股东大会会议资料 股东大会会议须知 为维护深圳微芯生物科技股份有限公司(以下简称"公司")全 体股东在公司股东大会(以下简称"本次会议")期间的合法权益, 确保股东大会的正常秩序和议事效率,保证会议顺利进行,根据《中 华人民共和国公司法》(以下简称"公司法")《中华人民共和国证券 法》(以下简称"证券法")《上市公司股东大会规则》以及《深圳微 芯生物科技股份有限公司章程》(以下简称"公司章程")《深圳微芯 生物科技股份有限公司 ...
11月27日A股投资避雷针︱*ST东通:深交所拟终止公司股票上市交易;*ST亚太:公司股票交易被叠加实施退市风险警示





Ge Long Hui· 2025-11-27 00:05
Summary of Key Points Core Viewpoint - Several shareholders across various companies are planning to reduce their stakes, indicating potential shifts in ownership and market dynamics [1] Shareholder Reductions - Southern Precision's actual controller's concerted action party plans to reduce holdings by no more than 2.54% [1] - Huasheng Lithium's shareholder Dunxing Value intends to reduce holdings by up to 0.63% [1] - Yibo Technology's shareholder Lingyu Jicheng plans to reduce holdings by no more than 2.9834% [1] - Hesheng Co., Ltd. has multiple shareholders intending to collectively reduce holdings by no more than 3% [1] - Maike Biological's shareholder Guo Lei plans to reduce holdings by no more than 500,000 shares [1] - Chengyi Pharmaceutical's shareholders Chengyi Small Loan and Yan Xiaoling have completed a reduction of 3.8756 million shares [1] - Guoji Heavy Equipment's shareholders from Bank of China Deyang Branch and Bank of China Zhenjiang Runzhou Branch have collectively reduced holdings by 72.1355 million shares [1] - Debang Technology's shareholder National Integrated Circuit Fund has completed a reduction of 2.8448 million shares [1] - Other notable reductions include: - Yalian Youzhan's shareholder Qian Dejing reducing 0.5476% of company shares [1] - Feile Audio's Lingang Group reducing 24.569 million shares [1] - New Sharp's shareholder Xinhong Zhongfu planning to reduce up to 0.50% of shares [1] - Microchip Biotech's shareholder Boao Bio completing a reduction of 3% of company shares [1] - Zhejiang Zhongcheng's shareholder Chen Jian reducing 11.497 million shares [1] Other Notable Events - ST Dongdi is facing a proposed termination of its stock listing by the Shenzhen Stock Exchange [1] - ST Yatai's stock trading is subject to additional delisting risk warnings [1]
深圳微芯生物科技股份有限公司关于5%以上股东权益变动触及1%刻度暨减持股份结果公告
Shang Hai Zheng Quan Bao· 2025-11-26 17:46
Core Viewpoint - The announcement details the shareholding changes of Shenzhen Micu Biotechnology Co., Ltd. due to a reduction in shares by its major shareholder, BGI Group, which has completed its planned share reduction without affecting the company's control structure or governance [1][5]. Shareholder Holding Situation - Before the reduction plan, BGI Group held 34,705,162 shares, accounting for 8.51% of the total share capital of the company [1]. Reduction Plan Details - The reduction plan was disclosed on September 11, 2025, allowing BGI Group to reduce its holdings by up to 12,233,893 shares (3% of total shares) through a combination of centralized bidding and block trading [2]. - The actual reduction occurred between October 14 and November 26, 2025, with BGI Group successfully reducing its holdings by 12,233,893 shares, which is 3% of the total shares [2][4]. Impact of the Reduction - The reduction led to a decrease in the combined shareholding of BGI Group and Tianfu Qingyuan Holdings from 35,969,608 shares to 30,685,679 shares, reducing their combined ownership percentage from 8.82% to 7.52% [2][4]. - This change in shareholding does not trigger a mandatory tender offer and will not result in a change of control or significant impact on the company's governance or ongoing operations [3][5].